Adoptive T cell cancer therapy

被引：0
作者：
Karine N. Dzhandzhugazyan
Per Guldberg
Alexei F. Kirkin
机构：
[1] Danish Cancer Society Research Center,
[2] CytoVac A/S,undefined
来源：
Nature Materials | 2018年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Tumour heterogeneity and off-target toxicity are current challenges of cancer immunotherapy. Karine Dzhandzhugazyan, Per Guldberg and Alexei Kirkin discuss how epigenetic induction of tumour antigens in antigen-presenting cells may form the basis for multi-target therapies.
引用
收藏
页码：475 / 477
页数：2
相关论文
共 16 条
[1]  
Ribas A(2018)undefined Science 359 1350-1355
[2]  
Wolchok JD(2015)undefined Science 348 124-128
[3]  
Rizvi NA(2015)undefined Science 348 62-68
[4]  
Rosenberg SA(2018)undefined Science 359 1361-1365
[5]  
Restifo NP(2013)undefined J. Immunother. 36 133-151
[6]  
June CH(2016)undefined Science 351 1463-1469
[7]  
O’Connor RS(1991)undefined Science 254 1643-1647
[8]  
Kawalekar OU(2011)undefined J. Clin. Oncol. 29 917-924
[9]  
Ghassemi S(2018)undefined Nat. Commun. 9 1251-1260
[10]  
Milone MC(2015)undefined Cancer Immunol. Immunother. 64 undefined-undefined
12